Skip to main content

Table 1 Correlation between the expression levels of miR-145 and the clinicopathological characteristics of ESCC patients

From: miR-145 sensitizes esophageal squamous cell carcinoma to cisplatin through directly inhibiting PI3K/AKT signaling pathway

Clinical parameters Cases (n) miR-145 expression P-value
(*P < 0.05)
High (n) Low (n)
Gender
 Male 21 9 12 0.232
 Female 9 6 3  
Age
 < 60 17 7 10 0.269
 ≥ 60 13 8 5  
Tumor location
 Upper 7 3 4 0.753
 Middle 12 7 5  
 Lower 11 5 6  
Tumor size (cm)
 < 3 16 10 6 0.143
 ≥ 3 14 5 9  
Differentiation grade
 Well-moderate 23 12 11 0.666
 Poor-undifferentiation 7 3 4  
Lymph node metastasis
 Negative 15 10 5 0.068
 Positive 15 5 10  
TNM stage
 I–II 14 10 4 0.028*
 III–IV 16 5 11